The US Department of Justice (DOJ) has officially proposed, based on the recommendations from the Department of Health and Human Services, to reschedule Marijuana from a Schedule I to a Schedule III substance under the Controlled Substances Act (CSA). This is long overdue and, in my opinion, does not go far enough in the rescheduling of cannabis (marijuana was coined as a racial slur). The Marijuana Tax Act of 1937 and its subsequent prohibition had nothing to do with public health or smoking of the THC rich flower strains we associate with marijuana. It was purely a business lobbyists' ploy to eradicate hemp as it was the primary competition of the recently invented Nylon (rope), cotton (fabric), and wood pulp (paper). They lobbied the US Government, created a propaganda campaign, and the Big Lie was born. What many people don't realize is that up until then cannabis was such an important textile that farms were mandated to grow it. Its classification as a Schedule 1 narcotic under the Controlled Substance Act in 1970, advocated for by then President Richard Nixon (there's a trustworthy guy ;), was a political ploy to allow for the continued harassment and unwarranted incarceration of minorities following the Civil Rights Movement of the 1960's. The US government then put pressure on the rest of the world to follow suit. The late, great Robin Williams said it perfectly; "If the most dangerous thing about a 'drug' is getting caught with it, there's a real problem." Tens of millions of people and their families have been hurt due to their unfair incarceration for marijuana related ‘offenses’. In addition, countless innocent people have lost their lives as a result of the War on Drugs and its bolstering of gangs and cartels (by legalizing it the cartels have no business). Meanwhile the vast majority of the world has missed out on the many health benefits of cannabis-derived compounds and earth friendly hemp textiles. Today the Cannabis Industry is thriving in states where it has been legalized and thousands of businesses, who pay more than their fair share of federal, state, and local taxes, are employing hundreds of thousands of people while providing state tested, safe cannabis products. However, these businesses do not have the same tax deductions that other businesses are entitled to. Also, they do not have access to traditional financial services, such as banking and credit card transactions, and therefore are the target of criminals due to the cash nature of its commerce. We have let our governments brain wash us for too long. Let’s be done. Please take the time to comment at Regulations.gov before the July 22nd deadline.
Arnar Olgeirsson’s Post
More Relevant Posts
-
DOJ Marijuana Rescheduling Notice of Proposed Rulemaking A quick status as of 6/26/2024. With 26 days remaining in the original 60-day comment period, regulations.gov has received more than 25,000 comments to the proposal to reschedule marijuana from schedule I to schedule III. Several comments requesting an extension to the 60-day period have been received so it’s quite likely we’ll see an additional 30-days or more added to the comment period. In addition, several groups have requested a hearing on the matter which will likely extend any outcome. June 20th was the deadline to request a hearing. The decision whether to hold a hearing is made by the DEA administrator. Should DEA grant a hearing, a notice will be posted in the Federal Register establishing the date and time. An agency administrative law judge would preside over the proceedings. Here’s the webpage if you want to reference the issue directly: https://lnkd.in/g-miSPeM
Regulations.gov
regulations.gov
-
Marijuana Rescheduling Comment Period Opens On May 21, 2024, the US Department of Justice's Notice of Proposed Rulemaking (NPRM) to reschedule marijuana from Schedule I to Schedule III opened to receive comments. Here's a link to provide public comments: https://lnkd.in/g-miSPeM Comments are due on or before July 22, 2024 and must be submitted electronically or postmarked by that date. Hearing requests may be electronically transmitted or sent in by mail on or before June 20, 2024. Remember that your comments are publicly available on the regulations.gov website although you may request redaction of proprietary information. You can also go online to view other comments as they become available. Click on the blue "Comment" button to post. You can attach a file (such as a formal letter) in addition to providing text in a comment field. Comments are intended to assist the rulemaking agency as it considers the structure or viability of new regulations/requirements. They are not used to determine popularity as an opinion poll based on the number of comments received or views expressed.
Regulations.gov
regulations.gov
-
It’s been just about two weeks since comments opened on the Department of Justice’s proposed rule reclassifying marijuana from Schedule I to Schedule III. In that time, there have already been more than 10,500 comments submitted. There’s still lots of time to make your voice heard, so I put together a quick guide to this comment period. When? Comments must be submitted electronically or postmarked on or before 11:59 Eastern Time on July 22, 2024. Where? The DOJ encourages interested parties to submit comments electronically through the Federal eRulemaking Portal at https://lnkd.in/g6Qsq7kf How? On the Federal eRulemaking Portal you can find the text of the DOJ’s proposed rule and type short comments directly into the comment field or to attach a file for lengthier comments. Make sure to reference “Docket No. DEA-1362” on all comments and attachments so that your comment can be processed. Note that all comments received will be part of the public record. The DOJ will make comments available for public inspection online. So, don’t include any personally identifiable information or other information you don’t want disclosed.
Regulations.gov
regulations.gov
-
CEO and PR Powerhouse @ PRfect PR | I amplify voices, shape stories, and drive change through strategic communications and public relations
🌿 Policy Update: Cannabis in the Spotlight! 🌿 If you have heard yet, The DEA is proposing to reclassify marijuana from schedule I to schedule III under the Controlled Substances Act, highlighting its potential medical benefits. Speak up to help make this happen. 🔍 Why Should You Speak Up? Your expertise is essential in ensuring cannabis policy reflects its medical value and responsible regulation. Public comments are open until July 22, 2024, so act fast! Whether you're in healthcare, policy, or support regulatory reform, now is the time to make your voice heard. 📝 Comment Here: https://lnkd.in/gV6cTEZy Let's cultivate meaningful change together! #CannabisPolicy #DEA #PublicComment #HealthcarePolicy #Advocate
Regulations.gov
regulations.gov
-
Attention #cannabisindustry LAST DAY TO COMMENT IS TODAY! Summary The Department of Justice (“DOJ”) proposes to transfer marijuana from schedule I of the Controlled Substances Act (“CSA”) to schedule III of the CSA, consistent with the view of the Department of Health and Human Services (“HHS”) that marijuana has a currently accepted medical use as well as HHS's views about marijuana's abuse potential and level of physical or psychological dependence. The CSA requires that such actions be made through formal rulemaking on the record after opportunity for a hearing. If the transfer to schedule III is finalized, the regulatory controls applicable to schedule III controlled substances would apply, as appropriate, along with existing marijuana-specific requirements and any additional controls that might be implemented, including those that might be implemented to meet U.S. treaty obligations. If marijuana is transferred into schedule III, the manufacture, distribution, dispensing, and possession of marijuana would remain subject to the applicable criminal prohibitions of the CSA. Any drugs containing a substance within the CSA's definition of “marijuana” would also remain subject to the applicable prohibitions in the Federal Food, Drug, and Cosmetic Act (“FDCA”). DOJ is soliciting comments on this proposal. LET YOUR VOICE BE HEARD! Do you agree or disagree? Whatever your stance is you should voice it!! Today is the last day! https://lnkd.in/gdgxRtu2
Regulations.gov
regulations.gov
-
Human Resource Business Partner, Certified Diversity Executive (CDE), and Training Consultant at Training Marbles, Inc.
Employers - Marijuana Legalization is upon us. The public comment period is a critical time to voice your concerns regarding safety in the workplace. Here’s the link: https://lnkd.in/eUMgbr96
Regulations.gov
regulations.gov
-
NABIS has taken a step in what we hope will be a collective journey towards positive change in the cannabis industry. We've submitted a letter to the Drug Enforcement Administration advocating for the rescheduling of cannabis from Schedule I to Schedule III. This initiative is about the potential to address challenges many in our industry have long recognized. We believe rescheduling could lead to: - Expanded medical research opportunities - Improved financial access for cannabis businesses - Steps towards addressing social inequities Let's continue this important conversation together as we shape a more informed and equitable future for cannabis. Read more: https://lnkd.in/dxeG8iRJ #CannabisIndustry #Rescheduling #CannabisPolicyReform
Regulations.gov
regulations.gov
-
As founding members of VapeSAFER, The Blinc Group is happy to support the Drug Enforcement Administration’s proposal to reschedule #cannabis from Schedule I to Schedule III. This pivotal change recognizes the substantial scientific evidence supporting cannabis’s medical utility and its lower potential for abuse. As the unified voice of the cannabis vaping industry, VapeSAFER is dedicated to advocating for regulations that prioritize consumer safety and informed choice. 🔬 𝐀𝐝𝐯𝐨𝐜𝐚𝐭𝐢𝐧𝐠 𝐟𝐨𝐫 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐚𝐧𝐝 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧: we urge for updated rules to facilitate research on state-legal marijuana products, driving safer consumption methods and medical advancements. 🌿 𝐏𝐫𝐢𝐨𝐫𝐢𝐭𝐢𝐳𝐢𝐧𝐠 𝐇𝐚𝐫𝐦 𝐑𝐞𝐝𝐮𝐜𝐭𝐢𝐨𝐧: vaping reduces harmful combustion byproducts, offering a safer alternative to smoking and improving public health outcomes. 🛡️ 𝐏𝐫𝐨𝐭𝐞𝐜𝐭𝐢𝐧𝐠 𝐘𝐨𝐮𝐭𝐡 𝐚𝐧𝐝 𝐄𝐧𝐬𝐮𝐫𝐢𝐧𝐠 𝐑𝐞𝐬𝐩𝐨𝐧𝐬𝐢𝐛𝐥𝐞 𝐔𝐬𝐞: effective regulation prevents youth access while allowing responsible adult use. 💼 𝐒𝐮𝐩𝐩𝐨𝐫𝐭𝐢𝐧𝐠 𝐄𝐜𝐨𝐧𝐨𝐦𝐢𝐜 𝐑𝐞𝐥𝐢𝐞𝐟 𝐚𝐧𝐝 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐮𝐬𝐭𝐚𝐢𝐧𝐚𝐛𝐢𝐥𝐢𝐭𝐲: rescheduling provides tax relief to legal businesses, promoting market sustainability and consumer safety. Join us in creating a safer, informed cannabis vaping market. VapeSAFER is dedicated to working with regulators, industry stakeholders, and the public to promote thoughtful cannabis regulation. #CannabisRegulation #PublicHealth #CannabisResearch #HarmReduction #ResponsibleUse #MarketSustainability #NotJustVapor Paul Demko Gurpreet (Pete) Sahani Stephen Abraham Terra Boldt Sasha Aksenov Seth Dean Nathan Clay Ryan Deegan Connor Corley Taylor C. Adrien Pla Pamela Epstein Douglas Fischer Drew Hull Laura Fogelman Joanna Cedar Luna Stower, MAT✨
As the unified voice of the #cannabis #vaping industry, we are proud to submit comments to the Drug Enforcement Administration on the rescheduling of marijuana —advocating for a robust and safe cannabis vape market that protects consumer safety and choice. VapeSAFER supports the proposed rescheduling of marijuana, recognizing the need for updated regulations that reflect the current understanding of marijuana's pharmacological effects and its impact on public health. Transitioning marijuana to Schedule III is justified by substantial scientific evidence supporting its medical utility and lower potential for abuse compared to Schedule II substances. If performed in a thoughtful manner, rescheduling will facilitate research and innovation, particularly concerning safer consumption methods such as vaporization. Thank you to those industry leaders who are part of our coatition and contributed to our comments. Read more at bit.ly/vapesafer-dea #drugpolicyreform #vapesafer
Regulations.gov
regulations.gov
-
One week ago, the comment period for the Rescheduling of Marijuana closed. 🔒 During the comment period, around 43,000 comments were received. Now that the comment period is closed, the next phase of the process begins, evaluating all the comments. If intrigued, read some of the comments for yourself. 👇 It will be very interesting to see what happens next! https://lnkd.in/gT9rHJ5B
Regulations.gov
regulations.gov
-
MCA Cannabis Community, The DEA’s decision to reschedule cannabis to Schedule III is open for the 60-day notice and comment period until July 22. This is a critical opportunity for us to shape the future of the cannabis industry and ensure our collective voice is heard. Potential Impacts of Rescheduling Cannabis to Schedule III ... Rescheduling cannabis from Schedule I to Schedule III could have profound effects on our industry, including: Improved Research Opportunities: Allowing more comprehensive scientific research into cannabis, its medical benefits, and potential risks. Eased Financial Restrictions: Potential reduction in the financial and banking challenges currently faced by cannabis businesses. Tax Relief: Changes to the application of IRC 280E will allow cannabis businesses to deduct ordinary business expenses and improve their overall financial viability. Regulatory Clarity: Providing more straightforward guidelines for the industry can lead to more consistent and fair regulatory practices. Social Equity Advancements: Promoting more equitable opportunities within the cannabis industry, ensuring that communities disproportionately affected by previous cannabis laws benefit from the industry’s growth. How to Submit Your Public Comment: To Submit Online: Visit regulations.gov. Alternatively, go to regulations.gov and search “Docket No. DEA-1362”. Type your comment directly or attach a file for lengthier comments. To Submit Via Mail: Include “Docket No. DEA-1362” on all correspondence. Mail paper submissions to: Drug Enforcement Administration Attn: DEA Federal Register Representative/DPW 8701 Morrissette Drive Springfield, Virginia 22152 Important Notes: Electronic comments must be submitted by 11:59 PM Eastern Time on the deadline date. Duplicate electronic and paper submissions are discouraged. Why Your Voice Matters? Our industry faces unique challenges and opportunities. By participating in this crucial dialogue, we can: - Influence fair regulatory practices. - Ensure sustainable growth and development for our businesses. - Protect the interests of our community and patients. - Promote social equity within the cannabis industry. Let’s come together to advocate for fair and sensible regulations. Your participation can lead to significant changes that benefit our entire community, including advancing social equity.
Regulations.gov
regulations.gov